Glow Lifetech Corp. (CSE:GLOW) Launches Products on Mendo Medical Cannabis Platform

Toronto, Ontario — January 7, 2026 — Leads & Copy — Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) has launched its MOD™ and .decimal™ product portfolio on the Mendo Medical Cannabis platform, marking Glow’s entry into the Canadian medical cannabis channel. This expansion provides registered medical patients nationwide with access to Glow’s products.

The launch makes Glow’s full portfolio of 14 SKUs of next-generation cannabis products available to medical patients across Canada, including veterans. These products are designed to offer greater consistency, dose-control, and personalization.

Mendo Medical Cannabis, based in Quebec, operates a national online sales platform (www.mendomedical.ca). The platform provides civilians and veterans with secure access to high-quality cannabis products from Canada’s licensed producers. Mendo has a focus on veterans through dedicated support programs.

Rob Carducci, CEO of Glow Lifetech, stated that the launch on Mendo expands Glow into a new channel, making its products accessible to medical cannabis patients across Canada. Carducci noted the relevance of medical-first frameworks and the company’s focus on medical-caliber science, aligning with Mendo’s focus on serving medical patients and veterans.

Josee Bissonnette, CEO of Mendo, said they are delighted to work with Glow to offer MOD™ and .decimal™ products to their members through their national sales portal. Bissonnette emphasized Mendo’s focus on providing patients access to innovative products, and expressed the belief that Glow’s offerings will resonate well with their patient community.

The addition of the medical channel diversifies Glow’s distribution mix heading into 2026 and reinforces the scalability of its business model. Alongside its presence with provincial retailers, this expansion positions the company to serve a broader customer base while maintaining focus on operational efficiency and long-term value creation.

Mendo operates from its facility in St. Jean Sur Richelieu, near Montreal. It offers a comprehensive online portal for medical cannabis patients in Canada, featuring a selection of products from licensed producers. Mendo’s mission is to provide high-quality medical cannabis to patients and veterans.

Glow Lifetech is a Canadian biotechnology company focused on producing nutraceutical and cannabinoid-based products with enhanced bioavailability, absorption, and effectiveness. Glow’s MyCell Technology® delivery system transforms natural compounds into water-compatible concentrates.

Rob Carducci, CEO
Glow Lifetech Corp.
TF. 855-442-GLOW (4569)
ir@glowlifetech.com

Source: Glow Lifetech Corp

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.